Ionis Pharmaceuticals (IONS) PT Lowered to $84 at Needham & Company, Following Earnings

May 5, 2021 3:14 PM EDT
Get Alerts IONS Hot Sheet
Price: $37.81 --0%

Rating Summary:
    8 Buy, 10 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 9 | Down: 12 | New: 36
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Needham & Company analyst Chad Messer lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $84.00 (from $86.00) while maintaining a Buy rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change

Related Entities

Needham & Company, Earnings